| Autor: |
Kukava NG; Institute of Clinical Cardiology named after A.L. Myasnikov, National Cardiology Research Center., Shkhnovich RM; Institute of Clinical Cardiology named after A.L. Myasnikov, National Cardiology Research Center; Medical Academy of Continuing Education Russian Medical Academy of Postgraduate Education., Osmak GZ; Institute of Experimental Cardiology, National Medical Research Center for Cardiology., Baulina NM; Institute of Experimental Cardiology, National Medical Research Center for Cardiology., Matveeva NA; Institute of Experimental Cardiology, National Medical Research Center for Cardiology., Favorova OO; Institute of Experimental Cardiology, National Medical Research Center for Cardiology. |
| Jazyk: |
ruština |
| Zdroj: |
Kardiologiia [Kardiologiia] 2019 Oct 14; Vol. 59 (10), pp. 78-87. Date of Electronic Publication: 2019 Oct 14. |
| DOI: |
10.18087/cardio.2019.10.n558 |
| Abstrakt: |
Coronary artery disease is the most clinically significant manifestation of atherosclerosis and the main cause of morbidity and mortality around the world. Atherogenesis is a complex process, involving various types of cells and regulatory molecules. MicroRNA molecules were discovered at the end of the 20th century, and nowadays are the important regulators of several pathophysiological processes of atherogenesis. The review examines data on the participation of various microRNAs in the development of atherosclerosis and its main clinical manifestations and discusses the possibility of using microRNAs as diagnostic markers for these diseases. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
